A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease. [electronic resource]
Producer: 20110126Description: 367-75 p. digitalISSN:- 1755-3245
- Animals
- Apolipoprotein E3 -- genetics
- Aprotinin -- biosynthesis
- Atherosclerosis -- genetics
- Carotid Arteries -- surgery
- Cattle
- Cell Line
- Cell Proliferation
- Disease Models, Animal
- Electroporation
- Fibrinolysin -- antagonists & inhibitors
- Genetic Therapy -- methods
- Graft Occlusion, Vascular -- genetics
- Humans
- Hypercholesterolemia -- genetics
- Hyperplasia
- Male
- Matrix Metalloproteinase Inhibitors
- Matrix Metalloproteinases -- metabolism
- Mice
- Mice, Inbred C57BL
- Mice, Mutant Strains
- Receptors, Urokinase Plasminogen Activator -- metabolism
- Recombinant Fusion Proteins -- biosynthesis
- Saphenous Vein -- metabolism
- Time Factors
- Tissue Culture Techniques
- Tissue Inhibitor of Metalloproteinase-1 -- biosynthesis
- Transfection
- Urokinase-Type Plasminogen Activator -- biosynthesis
- Venae Cavae -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.